BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shields LBE, Daniels MW, Mar N, Rezazadeh Kalebasty A. Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy. World J Clin Oncol 2021; 12(3): 183-194 [PMID: 33767973 DOI: 10.5306/wjco.v12.i3.183]
URL: https://www.wjgnet.com/2218-4333/full/v12/i3/183.htm
Number Citing Articles
1
Wojciech Michalski, Grażyna Poniatowska, Joanna Jońska‐Gmyrek, Agnieszka Żółciak‐Siwińska, Inga Zastawna, Artur Lemiński, Anna Macios, Michał Jakubczyk, Tomasz Demkow, Paweł Wiechno. Simple yet (more?) effective. Venous thromboembolism risk assessment model for germ cell tumour patients receiving first‐line chemotherapyCancer Medicine 2023; 12(18): 18542 doi: 10.1002/cam4.6458
2
A.T. Meuleman, E.L.D. Volders, S. Lubberts, J.M. Kerst, A.N.M. Wymenga, M.J.B. Aarts, M.B. Goncalves, J.D. Lefrandt, G. Steursma, J. Meijer, J. Nuver, J.A. Gietema. Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular eventsESMO Open 2024; 9(7): 103631 doi: 10.1016/j.esmoop.2024.103631
3
Wojciech Michalski, Anna Macios, Grażyna Poniatowska, Inga Zastawna, Tomasz Demkow, Paweł Wiechno. Simple, Effective and Validated. VTE CASE Risk Assessment Score for Venous Thromboembolism in Metastatic Germ Cell Tumour Patients Before First‐Line ChemotherapyCancer Medicine 2024; 13(19) doi: 10.1002/cam4.70295
4
Landon C. Brown, Myra Robinson, Michael McCormack, Nury Steuerwald, James Symanowski, Wei Sha, Rupali Bose, Brittany Neelands, Tobi Akinyelu, Chad Livasy, Wencheng Li, Nathanael Haynes, Alicia Hamilton, Mathew Smith, Peter E. Clark, Jai Patel, Earle F. Burgess. Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With ChemotherapyClinical Genitourinary Cancer 2024; 22(3): 102086 doi: 10.1016/j.clgc.2024.102086
5
Ranmali Ranasinghe, Michael L. Mathai, Anthony Zulli. Cisplatin for cancer therapy and overcoming chemoresistanceHeliyon 2022; 8(9): e10608 doi: 10.1016/j.heliyon.2022.e10608